Initial Education for Rehabilitation and Motivation Program Following a Myocardial Infarction Via SMS or Hospital
February 8, 2018 updated by: Hillel Yaffe Medical Center
Initial Education for Rehabilitation and Motivation Program Following a Myocardial Infarction. Rehabilitation Exercises at Home Via SMS or in the Hospital Physiotherapy Department
The innovation in this preliminary study is the use of message reminders in patients after myocardial infarction in stage I of rehabilitation (ie discharge from hospital) at home via SMS, compared with studies of patients undergoing cardiac rehabilitation (stage II)in the hospital physiotherapy department.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The first stage of rehabilitation begins during hospitalization.
Motivation for the rehabilitation process for the patient.
At this stage there will be preparation for release and guidance for the patient and their families regarding secondary prevention and return to domestic activity.
This stage includes mobility, walking, controlled motility and gradual joint activation to maintain ranges and prevent complications from prolonged immobilization in bed.
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Informed consent Criteria for inclusion Patients after acute myocardial infarction admitted to the intensive care unit Patients who speak the Hebrew language Patients with a cell phone to receive a reminder using a message
Exclusion criteria:
Orthopedic or neurological problem that would prevent physical activity. A score lower than 24 in the MoCA test. High-risk patients.
Complications: of myocardial infarction congestive heart failure, cardiogenic shock and / or ventricular arrhythmias.
Angina or shortness of breath at rest. Decrease >1mm in the ST segment in the ECG.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Study group SMS to home phone
A physical reminder by a physiotherapist, and a daily reminder of physical exercise by SMS on weekdays A through E.
|
Cardiac rehabilitation
Other Names:
|
|
Other: Controlled group hospital based
Physical rehabilitation in the ward physiotherapist
|
Cardiac rehabilitation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac rehabilitation
Time Frame: 1 month
|
Cardiac rehabilitation following heart attack following discharge
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Avraham Shotan, Prof, Hillel Yaffe MC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2018
Primary Completion (Anticipated)
January 1, 2019
Study Completion (Anticipated)
January 1, 2019
Study Registration Dates
First Submitted
January 29, 2018
First Submitted That Met QC Criteria
February 8, 2018
First Posted (Actual)
February 9, 2018
Study Record Updates
Last Update Posted (Actual)
February 9, 2018
Last Update Submitted That Met QC Criteria
February 8, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HYMC-0131-17
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.